Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
ROSUVASTATIN (ROSUVASTATIN CALCIUM)
GENERIC MEDICAL PARTNERS INC
C10AA07
ROSUVASTATIN
5MG
TABLET
ROSUVASTATIN (ROSUVASTATIN CALCIUM) 5MG
ORAL
30/100
Prescription
HMG-COA REDUCTASE INHIBITORS
Active ingredient group (AIG) number: 0148963004; AHFS:
APPROVED
2013-01-08
MED-ROSUVASTATIN (rosuvastatin calcium tablets) Page 1 of 50 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR MED-ROSUVASTATIN rosuvastatin calcium tablets Tablets, 5, 10, 20 and 40 mg rosuvastatin (as rosuvastatin calcium), Oral Use Lipid Metabolism Regulator Generic Medical Partners Inc. 1500 Don Mills Road, Suite 711 Toronto, Ontario M3B 3K4 Date of Initial Authorization: JAN 08, 2013 Date of Revision: JAN 13, 2023 Submission Control Number: 268041 MED-ROSUVASTATIN (rosuvastatin calcium tablets) Page 2 of 50 RECENT MAJOR LABEL CHANGES Not applicable TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. RECENT MAJOR LABEL CHANGES.......................................................................................2 TABLE OF CONTENTS ...........................................................................................................2 PART I: HEALTH PROFESSIONAL INFORMATION................................................................4 1 INDICATIONS ..............................................................................................................4 1.1 Pediatrics............................................................................................................4 1.2 Geriatrics ............................................................................................................4 2 CONTRAINDICATIONS ................................................................................................4 4 DOSAGE AND ADMINISTRATION ...............................................................................5 4.1 Dosing Considerations ........................................................................................5 4.2 Recommended Dose and Dosage Adjustment .....................................................5 4.4 Administration .....................................................................................................7 4.5 Missed Dose ................................................................ Կարդացեք ամբողջական փաստաթուղթը